Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aphios Corporation
Aphios Corporation Awarded Japanese Patent for Phospholipid Nanosomes Technology Platform
June 11th, 2008
Aphios Corporation announced that it has been awarded a Japanese Patent No. 4,107,680, issued on April 11, 2008, for its phospholipid nanosomes technology platform for the encapsulation of hydrophobic drugs. Phospholipid nanosomes are small, uniform liposomes manufactured utilizing SuperFluids(TM). SuperFluids(TM) are normally gases which, when compressed, exhibit enhanced solvation, penetration and expansive properties. These fluids are reverse-engineered to form phospholipid nanosomes for encapsulating and improving the delivery of protein therapeutics, vaccine antigens and sRNAi molecules as well as small molecule therapeutics and hydrophobic drugs such as...
Source: Vaccine Weekly (2008-06-11)
|
